Merck & Co., Inc. (NYSE:MRK) Receives $119.35 Consensus Target Price from Brokerages
Shares of Merck & Co., Inc. (NYSE:MRK – Get Rating) have received an average recommendation of “Moderate Buy” from the twenty-four analysts that are currently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The average twelve-month price objective […]